Nanosonics Ltd risk profile

33 Normal where most of the sector sits

Measured 21 October 2026 from NAN's filed statements. Recomputed nightly.

33 (Normal), driven by Market expectation at 60, over 4 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation60StretchedStableDrawdown from the 52-week high — 39.5%
Operating pressure24NormalEasingCosts outgrowing revenue — -4.7 percentage points
Cash conversionReads operating_cashflow, capital_expenditure, free_cashflow, net_income and revenue. No reading is stored for this company.
Leverage and coverage0ContainedStableNet debt to EBITDA — -4.83x
Competitive position44ElevatedStableR&D-intensity gap against peers — -9.7 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Nanosonics Ltd